IDEXX LABORATORIES INC /DE (IDXX)
About IDEXX LABORATORIES INC /DE
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $4.3B
- Net income
- $1.1B
- Total assets
- $3.4B
- Market cap
- $42.9B
- Gross margin
- 61.8%
- Operating margin
- 31.6%
- Net margin
- 24.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $4.3B
- Cost of revenue
- $1.6B
- Gross profit
- $2.7B
- Operating expenses
- $1.3B
- Operating income
- $1.4B
- Income tax
- $264.7M
- Net income
- $1.1B
- EPS (basic)
- $13.17
- EPS (diluted)
- $13.08
Balance sheet
- Total assets
- $3.4B
- Current assets
- $1.4B
- Total liabilities
- $1.7B
- Current liabilities
- $1.1B
- Shareholders’ equity
- $1.6B
Cash flow
- Operating cash flow
- $1.2B
- Investing cash flow
- -$136.2M
- Financing cash flow
- -$1.2B
- Net cash flow
- -$108.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $42.9B
- P/E ratio
- 41.7
- EPS (diluted)
- $13.08
- Shares outstanding
- 78.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 21, 1991
Idexx Laboratories Inc /DE (IDXX) Stock Price
- Profitable — net income of $1.1B in FY2025.
- Revenue grew 34% from FY2021 to FY2025.
- Gross margin of 61.8%, net margin 24.6%.
- Trading 29% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 41.7.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review IDEXX LABORATORIES INC /DE.
Write a review
News about IDEXX LABORATORIES INC /DE
News & sentiment via Polygon.io
Idexx Laboratories Inc /DE: frequently asked questions
Is Idexx Laboratories Inc /DE an American company?
Yes — Idexx Laboratories Inc /DE is an American company headquartered in Westbrook, Maine. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Idexx Laboratories Inc /DE headquartered?
Idexx Laboratories Inc /DE is headquartered in Westbrook, Maine, United States.
Is Idexx Laboratories Inc /DE publicly traded?
Yes — Idexx Laboratories Inc /DE is a publicly traded company. Its stock trades under the ticker symbol IDXX on the NASDAQ.
What does Idexx Laboratories Inc /DE do?
Idexx Laboratories Inc /DE is an American Medical Devices company in the Health & Beauty sector.
